Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

25.99
-2.0000-7.15%
Post-market: 25.45-0.5400-2.08%19:59 EDT
Volume:27.69M
Turnover:712.35M
Market Cap:5.77B
PE:48.83
High:27.09
Open:26.30
Low:23.97
Close:27.99
Loading ...

Hims & Hers Shares Drop 17.3% Premarket After Co Warns It May Stop Selling Compounded Weight-Loss Drugs

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Inc : Piper Sandler Raises Target Price to $35 From $24

THOMSON REUTERS
·
25 Feb

Hims & Hers (HIMS) Sees 69% Revenue Increase Despite GLP-1 Uncertainties

TIPRANKS
·
25 Feb

24H|Medical AI Stocks Fall; Hims & Hers Health Drops 19%; Tempus AI Tumbles 14%; Palantir and Zoom Decline 3%

Tiger Newspress
·
25 Feb

Stock Track | Hims & Hers Plunges Over 18% After-Hours on Concerns Over Weight Loss Drug Business

Stock Track
·
25 Feb

Hims & Hers Stock Tumbles Despite Beating Expectations

Dow Jones
·
25 Feb

Stocks to Watch: Hims & Hers Health, Chegg, Wah Fu Education Group

Dow Jones
·
25 Feb

Hims & Hers Expects Customers to Return to Branded Weight Loss Drugs -- Market Talk

Dow Jones
·
25 Feb

Hims & Hers warns it may stop selling compounded weight-loss drugs

Reuters
·
25 Feb

BRIEF-Hims & Hers Health FDA Resolved Semaglutide Shortage

Reuters
·
25 Feb

Hims & Hers Health, Inc. (HIMS) Lags Q4 Earnings Estimates

Zacks
·
25 Feb

Hims & Hers warns its supply of compounded weight loss drugs could be 'constrained'

Reuters
·
25 Feb

Hims & Hers Health: FDA Resolved Semaglutide Shortage, Which Could Constrain Co's Ability to Continue Providing Access to Compounded Semaglutide

THOMSON REUTERS
·
25 Feb

Hims & Hers Shares Sink Despite Upbeat Earnings, Outlook

Dow Jones
·
25 Feb

Hims & Hers Health Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Feb

Hims & Hers Q4 Earnings, Revenue Rise; Issues Outlook; Shares Fall After-Hours

MT Newswires Live
·
25 Feb

HIMS Earnings: Shares Sink despite Smashing Guidance Estimates

TIPRANKS
·
25 Feb

Stock Track | Hims & Hers Health Plunges 20% After-Hours Despite Q4 Earnings Beat on Growth Outlook Miss

Stock Track
·
25 Feb

Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat

Benzinga
·
25 Feb

Hims & Hers Health Q4 2024 GAAP EPS $0.11, Inline, Sales $481.14M Beat $470.31M Estimate

Benzinga
·
25 Feb